Dorrit T. Andersen

General Counsel at

Galecto Biotech ApS

Health Technology

Consumer Services

Profile

Dorrit T.
Andersen is currently working as a Regulatory Director at Galecto Biotech ApS.
Prior to this, she worked as a Director-Global Regulatory Affairs at Novo Nordisk A, Manager-Regulatory Affairs at Genmab A and Symphogen A, and Head-Regulatory Affairs at Ciba-Geigy Denmark.
Andersen completed her undergraduate degree at the University of Copenhagen.

Dorrit T. Andersen active positions

Companies	Position	Start
Galecto Biotech ApS Galecto Biotech ApS Provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer	General Counsel	-

All active positions of Dorrit T. Andersen

Former positions of Dorrit T. Andersen

Companies	Position	End
Ciba-Geigy Denmark	General Counsel	-
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Provides antibody therapeutics for the treatment of cancers	General Counsel	-
GENMAB A/S	General Counsel	-
NOVO NORDISK A/S	General Counsel	-

See the detail of Dorrit T. Andersen's experience

Training of Dorrit T. Andersen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dorrit T. Andersen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Genmab A/S Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Provides antibody therapeutics for the treatment of cancers	Health Technology
Ciba-Geigy Denmark
Galecto Biotech ApS Galecto Biotech ApS Provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer

See company connections

Stock Market
Insiders
Dorrit T. Andersen